Mitigation and education

Journal of Orthopaedic Research

Volumn 32, Issue SUPPL.1, 2014, Pages

  Aggarwal, Vinay K ^a   Tischler, Eric H ^a   Lautenbach, Charles ^a   Williams Jr , Gerald R ^a   Abboud, Joseph A ^a   Altena, Mark ^a   Bradbury, Thomas ^a   Calhoun, Jason ^a   Dennis, Douglas ^a   Del Gaizo, Daniel J ^a   Font Vizcarra, Lluís ^a   Huotari, Kaisa ^a   Kates, Stephen ^a   Koo, Kyung Hoi ^a   Mabry, Tad M ^a   Moucha, Calin Stefan ^a   Palacio, Julio Cesar ^a   Peel, Trisha Nicole ^a   Poolman, Rudolf W ^a   Robb III, William J ^a   Salvagno, Ralph ^a   Seyler, Thorsten ^a   Skaliczki, Gabor ^a   Vasarhelyi, Edward M ^a   Watters III, William Charles ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; ADALIMUMAB; ALLOPURINOL; ANTIBIOTIC AGENT; ANTIGOUT AGENT; AZATHIOPRINE; BIOLOGICAL RESPONSE MODIFIER; COLCHICINE; ETANERCEPT; GOLIMUMAB; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PROBENECID; PSEUDOMONIC ACID; RITUXIMAB; SALAZOSULFAPYRIDINE; TOCILIZUMAB; ANTIINFECTIVE AGENT;

ALCOHOL CONSUMPTION; ANTIBIOTIC THERAPY; ARTHROPLASTY; BACTEREMIA; BACTERIAL ARTHRITIS; BACTERIAL COLONIZATION; CONSENSUS; COST EFFECTIVENESS ANALYSIS; DRUG HALF LIFE; ELECTIVE SURGERY; HEALTH CARE PERSONNEL; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; INTRAVENOUS DRUG ABUSE; JOINT PROSTHESIS; KIDNEY DISEASE; LIVER DISEASE; MALNUTRITION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MORBID OBESITY; MOUTH HYGIENE; NOTE; PATIENT HISTORY OF SURGERY; PERIPROSTHETIC JOINT INFECTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REHABILITATION CARE; SCREENING; SEPTICEMIA; SMOKING; SURGICAL INFECTION; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; URINALYSIS; ARTHRITIS, INFECTIOUS; CONSENSUS DEVELOPMENT; FEMALE; MALE; MASS SCREENING; PROSTHESIS-RELATED INFECTIONS; RISK FACTOR; STAPHYLOCOCCAL INFECTIONS; SURGICAL WOUND INFECTION;

ANTI-BACTERIAL AGENTS; ARTHRITIS, INFECTIOUS; ARTHROPLASTY, REPLACEMENT; FEMALE; HUMANS; MALE; MASS SCREENING; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MUPIROCIN; ORAL HYGIENE; PROSTHESIS-RELATED INFECTIONS; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; SURGICAL WOUND INFECTION;

EID: 84895825774     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.22547     Document Type: Note

References (107)

1. Cherney DL, Amstutz HC. 1983. Total hip replacement in the previously septic hip. J Bone Joint Surg Am 65:1256-1265.
2. Jupiter JB, Karchmer AW, Lowell JD, et al. 1981. Total hip arthroplasty in the treatment of adult hips with current or quiescent sepsis. J Bone Joint Surg Am 63:194-200.
3. Cruess RL, Bickel WS, vonKessler KL. 1975. Infections in total hips secondary to a primary source elsewhere. Clin Orthop Relat Res 99-101.
4. del Sel HJ, Charnley J. 1979. Total hip replacement following infection in the opposite hip. Clin Orthop Relat Res 138-142.
5. Fitzgerald RH Jr., Nolan DR, Ilstrup DM, et al. 1977. Deep wound sepsis following total hip arthroplasty. J Bone Joint Surg Am 59:847-855.
6. Hanssen AD, Rand JA. 1999. Evaluation and treatment of infection at the site of a total hip or knee arthroplasty. Instr Course Lect 48:111-122.
7. Schmalzried TP, Amstutz HC, Au MK, et al. 1992. Etiology of deep sepsis in total hip arthroplasty. The significance of hematogenous and recurrent infections. Clin Orthop Relat Res 200-207.
8. Stinchfield FE, Bigliani LU, Neu HC, et al. 1980. Late hematogenous infection of total joint replacement. J Bone Joint Surg Am 62:1345-1350.
9. Thomas BJ, Moreland JR, Amstutz HC. 1983. Infection after total joint arthroplasty from distal extremity sepsis. Clin Orthop Relat Res 121-125.
10. Hanssen AD, Osmon DR, Nelson CL. 1997. Prevention of deep periprosthetic joint infection. Instr Course Lect 46:555-567.
11. Peersman G, Laskin R, Davis J, et al. 2001. Infection in total knee replacement: a retrospective review of 6489 total knee replacements. Clin Orthop Relat Res 15-23.
12. American Diabetes Association. 2013. Standards of medical care in diabetes-2013. Diabetes Care 36(Suppl 1):S11-S66.
13. Jamsen E, Nevalainen P, Kalliovalkama J, et al. 2010. Preoperative hyperglycemia predicts infected total knee replacement. Eur J Intern Med 21:196-201.
14. Marchant MH Jr., Viens NA, Cook C, et al. 2009. The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty. J Bone Joint Surg Am 91:1621-1629.
15. Pomposelli JJ, Baxter JK III, Babineau TJ, et al. 1998. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. JPEN J Parenter Enteral Nutr 22:77-81.
16. Adams AL, Paxton EW, Wang JQ, et al. 2013. Surgical outcomes of total knee replacement according to diabetes status and glycemic control, 2001 to 2009. J Bone Joint Surg Am 95:481-487.
17. Iorio R, Williams KM, Marcantonio AJ, et al. 2012. Diabetes mellitus, hemoglobin A1C, and the incidence of total joint arthroplasty infection. J Arthroplasty 27:726-729. e721.
18. Del Savio GC, Zelicof SB, Wexler LM, et al. 1996. Preoperative nutritional status and outcome of elective total hip replacement. Clin Orthop Relat Res 153-161.
19. Gherini S, Vaughn BK, Lombardi AV Jr., et al. 1993. Delayed wound healing and nutritional deficiencies after total hip arthroplasty. Clin Orthop Relat Res 188-195.
20. Jaberi FM, Parvizi J, Haytmanek CT, et al. 2008. Procrastination of wound drainage and malnutrition affect the outcome of joint arthroplasty. Clin Orthop Relat Res 466:1368-1371.
21. Lavernia CJ, Sierra RJ, Baerga L. 1999. Nutritional parameters and short term outcome in arthroplasty. J Am Coll Nutr 18:274-278.
22. Nicholson JA, Dowrick AS, Liew SM. 2012. Nutritional status and short-term outcome of hip arthroplasty. J Orthop Surg (Hong Kong) 20:331-335.
23. Jensen JE, Jensen TG, Smith TK, et al. 1982. Nutrition in orthopaedic surgery. J Bone Joint Surg Am 64:1263-1272.
24. Fletcher RH, Fairfield KM. 2002. Vitamins for chronic disease prevention in adults: clinical applications. JAMA 287:3127-3129.
25. Flegal KM, Carroll MD, Kit BK, et al. 2012. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 307:491-497.
26. Chen J, Cui Y, Li X, et al. 2013. Risk factors for deep infection after total knee arthroplasty: a meta-Analysis. Arch Orthop Trauma Surg 133:675-687.
27. Dowsey MM, Choong PF. 2009. Obese diabetic patients are at substantial risk for deep infection after primary TKA. Clin Orthop Relat Res 467:1577-1581.
28. Everhart JS, Altneu E, Calhoun JH. Medical comorbidities are independent preoperative risk factors for surgical infection after total joint arthroplasty. Clin Orthop Relat Res Mar 22 2013. Epub before print.
29. Malinzak RA, Ritter MA, Berend ME, et al. 2009. Morbidly obese, diabetic, younger, and unilateral joint arthroplasty patients have elevated total joint arthroplasty infection rates. J Arthroplasty 24:84-88.
30. Jibodh SR, Gurkan I, Wenz JF. 2004. In-hospital outcome and resource use in hip arthroplasty: influence of body mass. Orthopedics 27:594-601.
31. Peersman G, Laskin R, Davis J, et al. 2006. Prolonged operative time correlates with increased infection rate after total knee arthroplasty. HSS J 2:70-72.
32. McElroy MJ, Pivec R, Issa K, et al. 2013. The effects of obesity and morbid obesity on outcomes in TKA. J Knee Surg 26:83-88.
33. Freeman JT, Anderson DJ, Hartwig MG, et al. 2011. Surgical site infections following bariatric surgery in community hospitals: a weighty concern? Obes Surg 21:836-840.
34. Singh JA, Houston TK, Ponce BA, et al. 2011. Smoking as a risk factor for short-term outcomes following primary total hip and total knee replacement in veterans. Arthritis Care Res (Hoboken) 63:1365-1374.
35. Mills E, Eyawo O, Lockhart I, et al. 2011. Smoking cessation reduces postoperative complications: a systematic review and meta-Analysis. Am J Med 124:144-154. e148.
36. Myers K, Hajek P, Hinds C, et al. 2011. Stopping smoking shortly before surgery and postoperative complications: a systematic review and meta-Analysis. Arch Intern Med 171:983-989.
37. Sorensen LT. 2012. Wound healing and infection in surgery. The clinical impact of smoking and smoking cessation: a systematic review and meta-Analysis. Arch Surg 147:373-383.
38. Sorensen LT, Karlsmark T, Gottrup F. 2003. Abstinence from smoking reduces incisional wound infection: a randomized controlled trial. Ann Surg 238:1-5.
39. Sadr Azodi O, Bellocco R, Eriksson K, et al. 2006. The impact of tobacco use and body mass index on the length of stay in hospital and the risk of post-operative complications among patients undergoing total hip replacement. J Bone Joint Surg Br 88:1316-1320.
40. Lindstrom D, Sadr Azodi O, Wladis A, et al. 2008. Effects of a perioperative smoking cessation intervention on postoperative complications: a randomized trial. Ann Surg 248:739-745.
41. Harris AH, Reeder R, Ellerbe L, et al. 2011. Preoperative alcohol screening scores: association with complications in men undergoing total joint arthroplasty. J Bone Joint Surg Am 93:321-327.
42. Bradley KA, Rubinsky AD, Sun H, et al. 2011. Alcohol screening and risk of postoperative complications in male VA patients undergoing major non-cardiac surgery. J Gen Intern Med 26:162-169.
43. Tonnesen H, Rosenberg J, Nielsen HJ, et al. 1999. Effect of preoperative abstinence on poor postoperative outcome in alcohol misusers: randomised controlled trial. BMJ 318: 1311-1316.
44. Sunday JM, Guille JT, Torg JS. 2002. Complications of joint arthroplasty in patients with end-stage renal disease on hemodialysis. Clin Orthop Relat Res 350-355.
45. Lieberman JR, Fuchs MD, Haas SB, et al. 1995. Hip arthroplasty in patients with chronic renal failure. J Arthroplasty 10:191-195.
46. Sakalkale DP, Hozack WJ, Rothman RH. 1999. Total hip arthroplasty in patients on long-term renal dialysis. J Arthroplasty 14:571-575.
47. Pour AE, Matar WY, Jafari SM, et al. 2011. Total joint arthroplasty in patients with hepatitis C. J Bone Joint Surg Am 93:1448-1454.
48. Hsieh PH, Chen LH, Lee MS, et al. 2003. Hip arthroplasty in patients with cirrhosis of the liver. J Bone Joint Surg Br 85:818-821.
49. Cohen SM, Te HS, Levitsky J. 2005. Operative risk of total hip and knee arthroplasty in cirrhotic patients. J Arthroplasty 20:460-466.
50. Berbari EF, Osmon DR, Lahr B, et al. 2012. The Mayo prosthetic joint infection risk score: implication for surgical site infection reporting and risk stratification. Infect Control Hosp Epidemiol 33:774-781.
51. Guichelaar MM, Schmoll J, Malinchoc M, et al. 2007. Fractures and avascular necrosis before and after orthotopic liver transplantation: long-term follow-up and predictive factors. Hepatology 46:1198-1207.
52. Ramsey-Goldman R, Dunn JE, Dunlop DD, et al. 1999. Increased risk of fracture in patients receiving solid organ transplants. J Bone Miner Res 14:456-463.
53. Tannenbaum DA, Matthews LS, Grady-Benson JC. 1997. Infection around joint replacements in patients who have a renal or liver transplantation. J Bone Joint Surg Am 79:36-43.
54. Lehman CR, Ries MD, Paiement GD, et al. 2001. Infection after total joint arthroplasty in patients with human immunodeficiency virus or intravenous drug use. J Arthroplasty 16:330-335.
55. Habermann B, Eberhardt C, Kurth AA. 2008. Total joint replacement in HIV positive patients. J Infect 57:41-46.
56. Hicks JL, Ribbans WJ, Buzzard B, et al. 2001. Infected joint replacements in HIV-positive patients with haemophilia. J Bone Joint Surg Br 83:1050-1054.
57. Lee J, Singletary R, Schmader K, et al. 2006. Surgical site infection in the elderly following orthopaedic surgery. Risk factors and outcomes. J Bone Joint Surg Am 88:1705-1712.
58. Jamsen E, Huhtala H, Puolakka T, et al. 2009. Risk factors for infection after knee arthroplasty. A register-based analysis of 43,149 cases. J Bone Joint Surg Am 91:38-47.
59. Kurtz SM, Ong KL, Lau E, et al. 2010. Prosthetic joint infection risk after TKA in the Medicare population. Clin Orthop Relat Res 468:52-56.
60. Willis-Owen CA, Konyves A, Martin DK. 2010. Factors affecting the incidence of infection in hip and knee replacement: an analysis of 5277 cases. J Bone Joint Surg Br 92:1128-1133.
61. Dye BA, Tan S, Smith V, et al. 2007. Trends in oral health status: United States, 1988-1994 and 1999-2004. Vital Health Stat 1-92.
62. Bartzokas CA, Johnson R, Jane M, et al. 1994. Relation between mouth and haematogenous infection in total joint replacements. BMJ 309:506-508.
63. Barrington JW, Barrington TA. 2011. What is the true incidence of dental pathology in the total joint arthroplasty population? J Arthroplasty 26:88-91.
64. LaPorte DM, Waldman BJ, Mont MA, et al. 1999. Infections associated with dental procedures in total hip arthroplasty. J Bone Joint Surg Br 81:56-59.
65. Sandhu SS, Lowry JC, Morton ME, et al. 1997. Antibiotic prophylaxis, dental treatment and arthroplasty: time to explode a myth. J Bone Joint Surg Br 79:521-522.
66. Parvizi J, Della Valle CJ. 2010. AAOS Clinical Practice Guideline: diagnosis and treatment of periprosthetic joint infections of the hip and knee. J Am Acad Orthop Surg 18:771-772.
67. Perl TM, Golub JE. 1998. New approaches to reduce Staphylococcus aureus nosocomial infection rates: treating S. aureus nasal carriage. Ann Pharmacother 32:S7-S16.
68. Kenner J, O'Connor T, Piantanida N, et al. 2003. Rates of carriage of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in an outpatient population. Infect Control Hosp Epidemiol 24:439-444.
69. Schwarzkopf R, Takemoto RC, Immerman I, et al. 2010. Prevalence of Staphylococcus aureus colonization in orthopaedic surgeons and their patients: a prospective cohort controlled study. J Bone Joint Surg Am 92:1815-1819.
70. Kalmeijer MD, van Nieuwland-Bollen E, Bogaers-Hofman D, et al. 2000. Nasal carriage of Staphylococcus aureus is a major risk factor for surgical-site infections in orthopedic surgery. Infect Control Hosp Epidemiol 21:319-323.
71. Hacek DM, Robb WJ, Paule SM, et al. 2008. Staphylococcus aureus nasal decolonization in joint replacement surgery reduces infection. Clin Orthop Relat Res 466:1349-1355.
72. Schweizer M, Perencevich E, McDanel J, et al. 2013. Effectiveness of a bundled intervention of decolonization, prophylaxis to decrease Gram positive surgical site infections after cardiac or orthopedic surgery: systematic review, meta-Analysis. BMJ 346:f2743.
73. Kallen AJ, Wilson CT, Larson RJ. 2005. Perioperative intranasal mupirocin for the prevention of surgical-site infections: systematic review of the literature and metaanalysis. Infect Control Hosp Epidemiol 26:916-922.
74. van Rijen MM, Bonten M, Wenzel RP, et al. 2008. Intranasal mupirocin for reduction of Staphylococcus aureus infections in surgical patients with nasal carriage: a systematic review. J Antimicrob Chemother 61:254-261.
75. Johnson AJ, Daley JA, Zywiel MG, et al. 2010. Preoperative chlorhexidine preparation and the incidence of surgical site infections after hip arthroplasty. J Arthroplasty 25:98-102.
76. Cox RA, Conquest C. 1997. Strategies for the management of healthcare staff colonized with epidemic methicillinresistant Staphylococcus aureus. J Hosp Infect 35:117-127.
77. Muder RR, Brennen C, Goetz AM. 1993. Infection with methicillin-resistant Staphylococcus aureus among hospital employees. Infect Control Hosp Epidemiol 14:576-578.
78. Simmons BP, Munn C, Gelfand M. 1986. Toxic shock in a hospital employee due to methicillin-resistant Staphylococcus aureus. Infect Control 7:350.
79. Dutch Working Party for Infection Prevention. 2007. MRSA in nursing homes. www.wip.nl, Accessed 2013.
80. Garner JS. 1996. Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 17:53-80.
81. Mitteilung der Kommission fü r Krankenhaushygiene und Infektionsprävention am RKI. 1999. Empfehlung zur prä -vention und Kontrolle von methicillin-resist-enten Staphylococcus aureus-Stämmen (MRSA) in Krankenhäusern under anderen medizinischen Einrichtungen. Bundesgesundheitbsbl-Gesundheitsforsch-Geseun-dheitsschutz. 42:954-956.
82. Bowler I. 1997. Strategies for the management of healthcare staff colonized with epidemic methicillin-resistant Staphylococcus aureus. J Hosp Infect 36:321-322.
83. Lessing MP, Jordens JZ, Bowler IC. 1996. When should healthcare workers be screened for methicillin-resistant Staphylococcus aureus? J Hosp Infect 34:205-210.
84. Koulouvaris P, Sculco P, Finerty E, et al. 2009. Relationship between perioperative urinary tract infection and deep infection after joint arthroplasty. Clin Orthop Relat Res 467:1859-1867.
85. Ollivere BJ, Ellahee N, Logan K, et al. 2009. Asymptomatic urinary tract colonisation predisposes to superficial wound infection in elective orthopaedic surgery. Int Orthop 33:847-850.
86. Lawrence VA, Gafni A, Gross M. 1989. The unproven utility of the preoperative urinalysis: economic evaluation. J Clin Epidemiol 42:1185-1192.
87. Nicolle LE, Bradley S, Colgan R, et al. 2005. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 40:643-654.
88. Rajamanickam A, Noor S, Usmani A. 2007. Should an asymptomatic patient with an abnormal urinalysis (bacteriuria or pyuria) be treated with antibiotics prior to major joint replacement surgery? Cleve Clin J Med 74(Suppl 1): S17-S18.
89. Bozic KJ, Lau E, Kurtz S, et al. 2012. Patient-related risk factors for periprosthetic joint infection and postoperative mortality following total hip arthroplasty in Medicare patients. J Bone Joint Surg Am 94:794-800.
90. Schrama JC, Espehaug B, Hallan G, et al. 2010. Risk of revision for infection in primary total hip and knee arthroplasty in patients with rheumatoid arthritis compared with osteoarthritis: a prospective, population-based study on 108,786 hip and knee joint arthroplasties from the Norwegian Arthroplasty Register. Arthritis Care Res (Hoboken) 62:473-479.
91. Howe CR, Gardner GC, Kadel NJ. 2006. Perioperative medication management for the patient with rheumatoid arthritis. J Am Acad Orthop Surg 14:544-551.
92. Jain A, Maini R, Nanchahal J. 2004. Disease modifying treatment and elective surgery in rheumatoid arthritis: the need for more data. Ann Rheum Dis 63:602-603.
93. Giles JT, Bartlett SJ, Gelber AC, et al. 2006. Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis. Arthritis Rheum 55:333-337.
94. Momohara S, Kawakami K, Iwamoto T, et al. 2011. Prosthetic joint infection after total hip or knee arthroplasty in rheumatoid arthritis patients treated with nonbiologic and biologic disease-modifying antirheumatic drugs. Mod Rheumatol 21:469-475.
95. Grennan DM, Gray J, Loudon J, et al. 2001. Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery. Ann Rheum Dis 60:214-217.
96. Perhala RS, Wilke WS, Clough JD, et al. 1991. Local infectious complications following large joint replacement in rheumatoid arthritis patients treated with methotrexate versus those not treated with methotrexate. Arthritis Rheum 34:146-152.
97. Carpenter MT, West SG, Vogelgesang SA, et al. 1996. Postoperative joint infections in rheumatoid arthritis patients on methotrexate therapy. Orthopedics 19:207-210.
98. Health Canada Drug Product Database. May 28, 2013; http://hc-sc.gc.ca/ dhp-mps/prodpharma/databasdon/index-eng. php, 2013.
99. Le Dantec L, Maury F, Flipo RM, et al. 1996. Peripheral pyogenic arthritis. A study of one hundred seventy-nine cases. Rev Rhum Engl Ed 63:103-110.
100. Morgan DS, Fisher D, Merianos A, et al. 1996. An 18 year clinical review of septic arthritis from tropical Australia. Epidemiol Infect 117:423-428.
101. Ryan MJ, Kavanagh R, Wall PG, et al. 1997. Bacterial joint infections in England and Wales: analysis of bacterial isolates over a four year period. Br J Rheumatol 36:370-373.
102. Li SF, Cassidy C, Chang C, et al. 2007. Diagnostic utility of laboratory tests in septic arthritis. Emerg Med J 24:75-77.
103. Li SF, Henderson J, Dickman E, et al. 2004. Laboratory tests in adults with monoarticular arthritis: can they rule out a septic joint? Acad Emerg Med 11:276-280.
104. Margaretten ME, Kohlwes J, Moore D, et al. 2007. Does this adult patient have septic arthritis? JAMA 297:1478-1488.
105. Parvizi J, Jacovides C, Zmistowski B, et al. 2011. Definition of periprosthetic joint infection: is there a consensus? Clin Orthop Relat Res 469:3022-3030.
106. Spangehl MJ, Masri BA, O'Connell JX, et al. 1999. Prospective analysis of preoperative and intraoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties. J Bone Joint Surg Am 81:672-683.
107. Atkins BL, Athanasou N, Deeks JJ, et al. 1998. Prospective evaluation of criteria for microbiological diagnosis of prosthetic-joint infection at revision arthroplasty. The OSIRIS Collaborative Study Group. J Clin Microbiol 36:2932-2939.